The role of pharmacogenetics in capecitabine efficacy and toxicity

S. W. Lam, H. J. Guchelaar, E. Boven

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)9-22
JournalCancer Treatment Reviews
Volume50
DOIs
Publication statusPublished - Nov 2016

Cite this

@article{38ab70223cc646a6bcee252abc20b3bd,
title = "The role of pharmacogenetics in capecitabine efficacy and toxicity",
keywords = "Genetic polymorphisms, Capecitabine, Toxicity, Efficacy",
author = "Lam, {S. W.} and Guchelaar, {H. J.} and E. Boven",
year = "2016",
month = "11",
doi = "10.1016/j.ctrv.2016.08.001",
language = "English",
volume = "50",
pages = "9--22",
journal = "Cancer Treatment Reviews",
issn = "0305-7372",
publisher = "W.B. Saunders Ltd",

}

The role of pharmacogenetics in capecitabine efficacy and toxicity. / Lam, S. W.; Guchelaar, H. J.; Boven, E.

In: Cancer Treatment Reviews, Vol. 50, 11.2016, p. 9-22.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - The role of pharmacogenetics in capecitabine efficacy and toxicity

AU - Lam, S. W.

AU - Guchelaar, H. J.

AU - Boven, E.

PY - 2016/11

Y1 - 2016/11

KW - Genetic polymorphisms

KW - Capecitabine

KW - Toxicity

KW - Efficacy

U2 - 10.1016/j.ctrv.2016.08.001

DO - 10.1016/j.ctrv.2016.08.001

M3 - Article

VL - 50

SP - 9

EP - 22

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

SN - 0305-7372

ER -